Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...

COVID-19 vaccination significantly reduced anxiety and depression in patients with idiopathic pulmonary fibrosis (IPF), ...

Deuruxolitinib showed significant efficacy and safety in hair regrowth stimulation among adult patients with alopecia areata, ...

Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...

The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated ...

The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

High cumulative doses of epipodophyllotoxins were associated with the highest risk for survivors of childhood cancer of ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or ...

With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

Despite found associations, due to small sample sizes the researchers suggest readers interpret their findings with caution.